Compumedics (CMP.AX)

Overall impact
C (55)

Commentary

Compumedics is an average overall performer. With a 'C' rating of 55.1 for overall impact (52nd percentile compared to all companies), Compumedics ranks 154th out of 198 industry peers, behind Restoration Robotics, Corindus Vascular Robotics, Modular Medical and 150 others, and ahead of Axonics Modulation Technologies, Bionik Laboratories, ProSomnus, Inc. and 41 others. On top material causes for Compumedics's industry (Health Care Equipment & Supplies), Compumedics performs well in Child and Maternal Health (95.2 score), Disease Eradication (95.9), Accountable Institutions (85.2) and 60 other causes where it received an 'A' score and performs poorly in Fair Labor Practices (12.7 score), Equal Pay and Opportunity (32.4), Accountable Institutions (36.4) and 38 other causes where it received a 'D' or 'F' score.
Screens
Fur
Impact
Cause CMP.AX
Peer rank
Overall impact

Log in to view this information

Screens
Fur
Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
175
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Equipment
SASB industry
Medical Equipment & Supplies
Headquarters
Vic, Australia
Share classes
CMP.AX
Description
Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in Australia, the Asia Pacific, the United States, and Europe. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Okti; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST; Somté, an investigative tool; Siesta 802; and Somté PSG. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory studies; Grael 4K PSG:EEG amplifiers; Grael 4K-EEG amplifiers; Grael LT EEG System amplifiers; Neuvo 64-512 Channel LTM EEG monitoring systems; Okti, an portable EEG amplifier; and Siesta 802, a multi-functional ambulatory recording device. In addition, it offers software products, such as Profusion Sleep software suite; Profusion EEG Software; Profusion neXus 360, a web-based patient data and lab management system that offers integrated hardware and software solutions for sleep and neurology clinics; CURRY, a signal processing and soutce localization multi-modal neuroimaging suite; Profusion neXus Scheduler for planning for staff and time; and HD Digital Video, a plug-in software module to add synchronized digital video capabilities to sleep and EEG systems, as well as ECG Free, Profusion Plus, Siesta extended battery pack, summit IP, TCM5 FLEX transcutaneous monitors, Grael DC, and persyst software products. Further, the company offers magnetoencephalography systems; brain research technologies; pharmaceutical clinical trials and research services; and consumables and supplies for diagnostic and research solutions. Additionally, the company provides doppler diagnostics; Nuevo LTM EEG; Orion LifeSpan MEG; and quick-cap EEG electrode arrays. Compumedics Limited was incorporated in 1987 and is headquartered in Abbotsford, Australia. Compumedics Limited is a subsidiary of D & DJ Burton Holdings Pty Ltd.
Material causes
Ethos considers the following causes material for Compumedics, based on its industry sub-industry Health Care Equipment. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.